Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000899243-23-001157

Chief Financial Officer acquired 201 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Trigilio Jeffrey · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-12-30 Grant or award : show line 1 in the form +201 $8.97 $1,803 41,402 D
Loading xslF345X03/doc4.xml…